GOLDMAN SACHS GROUP INC - AQUINOX PHARMACEUTICALS INC ownership

AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 38 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AQUINOX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$77,000
-48.3%
26,298
+149.1%
0.00%
Q1 2018$149,000
-98.4%
10,558
-98.7%
0.00%
-100.0%
Q4 2017$9,542,000
-30.2%
811,371
-15.8%
0.00%
-33.3%
Q3 2017$13,667,000
+0.9%
963,147
+0.0%
0.00%
-25.0%
Q2 2017$13,548,000
-16.1%
962,896
-0.5%
0.00%0.0%
Q1 2017$16,153,000
+1.0%
967,832
-0.1%
0.00%
-20.0%
Q4 2016$15,995,000
+20.7%
968,819
-2.3%
0.01%
+25.0%
Q3 2016$13,248,000
+109.1%
991,597
+3.6%
0.00%
+100.0%
Q2 2016$6,336,000
-26.0%
957,166
-1.4%
0.00%
-33.3%
Q1 2016$8,558,000
+3703.6%
970,317
+5277.2%
0.00%
Q4 2015$225,00018,0450.00%
Other shareholders

There were no reported owners of AQUINOX PHARMACEUTICALS INC in Q4 2018.

NameSharesValueWeighting ↓
View complete list of AQUINOX PHARMACEUTICALS INC shareholders